Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the clinical-stage biotech company said a trial of a treatment for mild to moderate ...

Cassava Sciences Inc.’s stock crated 85% in premarket trade Monday, after the clinical-stage biotech said a trial of a treatment for mild-to-moderate Alzheimer’s disease failed to meet its main goals.

A survey by the Alzheimer's Society has found that many people who experience early signs of dementia mistake them for signs ...

The eyes can reveal a lot about the health of our brain. Indeed, problems with the eyes can be one of the earliest signs of ...

Paul Carpenter has created a tracking solution called BoundaryCare, it’s one of a growing number of companies that offer ...

It is critical to recognise dementia early on since it can improve care and quality of life for individuals affected. However ...

By Sukhman Rekh - Medically reviewed by Nicholas R. Metrus, MD Everyone experiences forgetfulness from time to time. You ...

A Stanford-trained doctor shares why metabolic dysfunction is behind most of the diseases we're seeing in the modern world.

"We took careful measures to enroll patients with mild-to-moderate [Alzheimer's disease]," Chief Executive Rick Barry said in prepared remarks. "Despite that, the loss of cognition in the placebo ...

Are there warning signs that I could watch for to help us ... "Someone with early-onset Alzheimer's who is younger than 65 can qualify for fast-track eligibility for Social Security Disability ...

A tracking device is helping parents of children with special needs stay connected, one mother says it has opened up her ...

Dear Quentin,  I have two sisters who have developed Alzheimer’s disease. My younger sister is actually more severely ...